Nurix Therapeutics, Inc. (NRIX) › Operating Cash FlowNurix Therapeutics, Inc. (NRIX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: $601.0K2020: -$80.0K2021: -$84.36M2022: -$159.81M2023: -$81.36M2024: -$172.58M2025: -$249.47M-$249.47M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$249.47M-44.5%2024-$172.58M-112.1%2023-$81.36M+49.1%2022-$159.81M-89.4%2021-$84.36M-105356.2%2020-$80.0K-113.3%2019$601.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share